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Objective: This cohort study was conducted to determine the effect on walking distances of supervised exercise therapy
provided in a community-based setting.
Methods: The study included all consecutive patients presenting at the vascular outpatient clinic with intermittent
claudication, diagnosed by a resting ankle brachial index<0.9, who had no previous peripheral vascular intervention for
peripheral arterial disease, no major amputation, and sufficient command of the Dutch language. The exclusion criterion
was the inability to walk the baseline treadmill test for a minimum of 10 m. The intervention was a supervised exercise
therapy in a community-based setting. A progressive treadmill test at baseline and at 1, 3, and 6 months of follow-up
measured initial claudication distance and absolute claudication distance. Changes were calculated using the mean
percentages of change.
Results: From January through October 2005, 93 consecutive patients with claudication were eligible. Overall, 37
patients discontinued the supervised exercise therapy program. Eleven stopped because of intercurrent diseases, whereas
for 10, supervised exercise therapy did not lead to adequate improvement and they underwent a vascular intervention.
Three patients quit the program, stating that they were satisfied with the regained walking distance and did not require
further supervised exercise therapy. Ten patients were not motivated sufficiently to continue the program, and in three
patients, a lack of adequate insurance coverage was the reason for dropping out. Data for 56 patients were used and
showed a mean percentage increase in initial claudication distance of 187% after 3 months and 240% after 6 months. The
mean percentage of the absolute claudication distance increased 142% after 3 months and 191% after 6 months.
Conclusion: Supervised exercise therapy in a community-based setting is a promising approach to providing conservative
treatment for patients with intermittent claudication. (J Vasc Surg 2007;45:1192-6.)Exercise therapy is highly efficacious for symptomatic
relief in peripheral arterial disease (PAD),1 but is usually
prescribed simply in the form of advice to “go home and
walk,” without supervision or follow-up.2,3 Yet, there is no
evidence to support the efficacy of this advice, and compli-
ance is known to be low.2,4 A recent Cochrane Review
identified a significant improvement in walking distance in
patients undergoing a supervised exercise therapy (SET)
program compared with those involved in a nonsupervised
program, with an increased difference in maximal walking
distance of approximately 150 m after 3 months.5 Factors
such as fear of pain, inadequate knowledge of the underly-
ing disease, and poor general condition, contribute to the
difficulty of starting, sustaining, and maintaining exercise
therapy.2 SET entails adequate coaching to increase the
maximal walking distance as well as coaching in the neces-
sary changes in lifestyle, such as smoking cessation, weight
control, and increase in overall exercise.
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1192Based on this difference with SET, we explored its local
implementation in a clinic-based setting; however, we had
to stop the study for various reasons. The main restriction
was the limited capacity of the in-hospital department of
rehabilitation and physiotherapy. Three half-hour sessions
weekly per patient proved overly time consuming in an
already busy department; as a consequence, only a limited
number of patients could be offered clinic-based SET.
Furthermore, transport to and from the hospital, especially
using public transportation, was costly for many patients as
well as time consuming. The initial phase of two to three
sessions weekly especially appeared to be problematic for
most of the patients. Some were too tired upon arriving at
the hospital to start training at all. Recorded drop-out rates
of up to 43% in the literature convinced us not to pursue
further clinic-based SET.6-8
This experience resulted in the development and im-
plementation of a new community-based concept of SET:
the Network for Exercise Therapy, Parkstad (NETP).9 In
this study, we hypothesized that the community-based
concept of well-distributed physiotherapeutic practices of-
fers SET closer to patients’ homes and thus lowers trans-
port costs and time. The NETP consists of 29 physiother-
apeutic practices equally dispersed over the southeastern
part of Limburg as well as theDepartment of Rehabilitation
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we also addressed the capacity problem.
PATIENTS AND METHODS
Study population. After implementation of the
NETP, patients with PAD who were eligible for SET were
referred to a nearby physiotherapist participating in the
network. All consecutive patients with intermittent claudi-
cation, diagnosed at the vascular laboratory by a resting
ankle brachial index (ABI) 0.9, who had no previous
vascular intervention for PAD, no major amputation (be-
low knee or more proximal), and sufficient command of the
Dutch language, were considered for community-based
SET. Patients were excluded from the analyses when the
absolute claudication distance (ACD) at baseline was10 m.
All patients received a platelet inhibitor and a statin as
recommended in the Dutch guidelines for PAD from the
Dutch Association of Surgery within the scope of secondary
prevention in patients with PAD.10 Patients were included
from January to October 2005.
Measurements. At baseline, the ABI was measured at
the vascular laboratory,11 and vascular risk factors, defined
as smoking, diabetes, hypertension, hypercholesterolemia,
myocardial infarction, angina pectoris, and stroke, were
registered by the vascular surgery nurse practitioner. For
smoking, patients were categorized as current smokers,
former smokers, and patients who never smoked. Diabetes
was noted with a serum fasting glucose level6.0 mmol/L
or if glucose-lowering medication was prescribed, or both.
Hypertension was noted for a blood pressure reading of
140/90 mm Hg or the use of antihypertensive medica-
tion, or both, and hypercholesterolemia was defined as a
serum total cholesterol level of5.0 mmol/L or the use of
cholesterol-lowering medication.
Walking distances were measured by a progressive
treadmill exercise test with a constant walking speed of 3.2
km/h beginning at 0% incline and increasing grade by 2%
every 2 minutes.12 The outcomes for walking distance were
the initial claudication distance (ICD) and absolute claudi-
cation distance (ACD). ICD was defined as the moment at
which the patient preferred to stop because of pain when no
supervision was provided. ACD was defined as the maximal
possible walking distance. ICD and ACD measurements
were taken at baseline and at 1, 3, and 6 months.
Exercise program. SET was administered according
to the guidelines of the Royal Dutch Society for Physio-
therapy.13 The mode of exercise was mainly treadmill walk-
ing up to maximal pain. Treadmill training was alternated
with cardiovascular training and strength training. During
the training sessions, walking patterns were corrected to
improve the quality of walking. In general, patients re-
ceived two to three sessions a week of approximately 30
minutes each in the initial phase, phasing down to once
every 2 weeks. Patients were also encouraged to exercise
daily by walking as much as possible to near-maximal pain.
Reimbursement from the tenth session through the
remainder of the 12 months is financed by National Insur-
ance of Health Care (AWBZ). Reimbursement for theinitial nine sessions depends on the patient’s insurance
policy.
Statistical analyses. The effects of community-based
SET on ICD and ACD were measured as outcome mea-
surements. These were expressed as the percentage increase
in walking distance compared with baseline. For each pa-
tient, the increase in ACD and ICD was calculated, and the
statistical significance of the increases was compared using
the paired Student t test. Patients who underwent a vascular
intervention during the SET period were excluded from
further analyses. A value of P  .05 was considered to be
statistically significant. Statistical analyses were performed
using SPSS 11.0 (SPSS Inc, Chicago, Ill).
We lacked a clinic-based SET control group because of
the above-mentioned limiting factors; thus, we compared
the increase in ICD and ACD of community-based SET
participants and drop-out rates with published data for
clinic-based SET from the Cochrane Review.5 Because five
of the seven studies in this review were limited to 6-month
follow-up periods, we present and compare the results of 6
months of community-based SET.
RESULTS
From January to October 2005, 93 consecutive pa-
tients with intermittent claudication were eligible for
community-based SET and were included in the study
cohort. During the 6-month study period, 37 patients
(39.8%) discontinued the program:
● Ten experienced insufficient symptom relief and were
unsatisfied with their claudication complaints and
eventually underwent a vascular intervention. Six re-
ceived a percutaneous transluminal angioplasty (PTA)
in one or both iliac arteries, three received a PTA in the
femoral artery, and one aortobifemoral bypass was
performed.
● Three patients quit the program at 3, 4, and 5 months
of SET, respectively, stating that they were satisfied
with the regained walking distance and did not require
further SET. Their 3-month results showed an increase
between 110% and 170% in ACD.
● Ten patients were not motivated sufficiently to con-
tinue the program, and none of these sought medical
attention for intermittent claudication elsewhere. In
three patients, a lack of adequate insurance coverage
was the reason for dropping out.
● Eleven quit the program because of emerging disease
consisting of cardiovascular in 6, orthopedic in 2, and
pulmonary, renal insufficiency, or ruptured abdominal
aortic aneurysm in 1 patient each; and 1patient died.
Data for the remaining 56 patients were used to analyze
the change in walking distance during the 6-month study
period. The baseline characteristics are summarized in Ta-
ble I, and no statistical difference compared with the with-
drawals was found in characteristics, with exception of the
presence of hypercholesterolemia (P  .02) and a prior
neurovascular event (P  .02). Two (3.6%) of the 56
patients had severe chronic heart failure. This cardiac co-
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to the Department of Physiotherapy and Rehabilitation in
our hospital instead of to a community-based physiothera-
pist.
Walking distances. At baseline, the mean ICD was
395 m (range, 55 to 1600 m), with a mean ACD of 563 m
(range, 60 to 1700m). After 3 months of SET, these values
improved to a mean ICD of 840 m (range, 180 to 2260 m)
and a mean ACD of 1154 m (range, 290 to 3740 m). The
means for both distances further increased after 6 months,
with a mean ICD of 1005 m (range, 210 to 3810 m) and a
mean ACD of 1312 m (range, 270 to 3980 m).
Translating these results to percentage increases, ICD
increased 187% and ACD increased 142% after 3 months.
After 6 months, the increase from the initial reading was
240% for ICD and 191% for ACD (Table II).
Community-based vs clinic-based supervised exer-
cise therapy. Earlier studies have reported ACD results
after SET compared with non-SET in patients with inter-
mittent claudication 4,6-8,14-16; however, in these studies,
SET was provided in a clinic-based setting and sample sizes
were small (range, 8 to 28 subjects). To compare these
results with those of our community-based SET study, we
summarized the reported ACD or absolute claudication
time (ACT) of the clinic-based SET groups for each fol-
low-up time point. For each trial, the percentage increase in
ACD or ACT was calculated as summarized in Table III.
After 3 months of clinic-based SET, increases between
35.3% and 137.0% were found, with a mean increase of
76%. After 6 months, an increase of 90% occurred (range,
42% to 159%).
DISCUSSION
SET provided in a patient’s home neighborhood in a
community-based physiotherapeutic setting resulted in a
Table I. Demographic and clinical characteristics
Characteristic*
Analyzed
population
(n  56)
Withdrawals
(n  37) P
Age (y) 64.0  10.4 64.7  10.8 NS
Men 35 (62.5) 25 (67.6) NS
BMI 26.3  3.9 26.1  3.9 NS
Current smokers 24 (42.9) 11 (29.7) NS
Ever smoked 19 (33.9) 13 (35.1) NS
Never smoked 13 (23.2) 10 (27.0) NS
Hypertension 45 (80.4) 31 (83.8) NS
Diabetes mellitus 23 (41.1) 13 (35.1) NS
Hypercholesterolemia 49 (87.5) 26 (70.3) .021
Coronary heart disease 16 (28.6) 9 (24.3) NS
Stroke or TIA 4 (7.1) 9 (24.3) .019
COPD 9 (16.1) 4 (10.8) NS
ABI 0.73  0.18 0.70  0.14 NS
ABI, Ankle brachial index; NS, not significant; BMI, body mass index;
COPD, chronic obstructive pulmonary disease; TIA, transient ischemic
attack.
*Continuous data are presented as mean  standard deviation; categoric
data are presented as number (%).highly statistically significant improvement in ACD after 3and 6 months. These results support the results of the
Cochrane Review comparing SET with non-SET, showing
clinical relevant differences in improvement of ACD after
SET.5 Although a comparison of our favorable results with
historical studies should be regarded with caution because
of the variability in the prescribed exercise regimens and
treadmill walking tests used, SET in a community-based
setting seems to be at least as efficacious as the programs
provided in a clinical setting.4,6-8,14-17
A difference between the clinic-based SET studies and
our cohort may be because our patients received SET
during the entire 6 months, whereas the exercise period in
three of seven of the earlier studies lasted only 3 months.
Because we studied consecutive patients who were
routinely referred to this new community-based supervised
exercise program, we were able to document carefully the
reasons for program discontinuation, as can also be done in
routine clinical practice. In our case, 37 patients (39.8%)
who were referred to the community-based SET did not
continue the program for the full 6-month period. About a
quarter of these patients stopped because of intercurrent
diseases, whereas for another quarter, SET did not lead to
adequate improvement and the patients had to undergo a
vascular intervention. Our overall recorded withdrawal rate
seems to be comparable with those of trials studying SET in
a clinic-based setting, which reported drop-out rates of up
to 43%.4,6,7
One of the possible pitfalls of community-based SET is
the use of numerous physiotherapeutic practices (n  30)
and physiotherapists (n  41), which results in a lower
patient volume for each physiotherapist than occurs in a
clinic-based setting. Consequently, this could lead to the
inability to build experience. For this reason, we decided to
implement a NETP and referred patients only to physio-
therapists who participated in this network, instead of to
any physiotherapist. Regular training sessions with all par-
ticipating physiotherapists in the NETP ensures shared
knowledge and experience. In addition, community-based
SET creates a larger capacity compared with clinic-based
SET, which means that a greater number of patients with
intermittent claudication can be treated.
Percutaneous transluminal angioplasty (PTA) of iliac
artery stenoses showed a weighted average 12-month pa-
tency rate of 78%, whereas PTA of the femoropopliteal
artery stenosis showed a weighted average primary patency
rate at 12 months of 61%.18 Our 60% success rate, which
might even be higher when successful drop-outs are in-
cluded, is comparable with the 12-month results of the
interventional therapy of intermittent claudication.
In the Netherlands, reimbursement of SET is currently
not a main issue for most patients. The main difficulty of
implementing SET seems to be convincing physicians that
SET is superior to non-SET; this difficulty is compounded
because the Dutch guidelines for general practitioners for
PAD (2003)19 and the guidelines for PAD of the Dutch
Society of Surgery (2005)10 advise starting non-SET in-
stead of SET. This advice probably persists because a Co-
chrane Review that showed a significant difference in in-
claudi
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therapy in favor of the supervised group had not yet ap-
peared when these guidelines were developed.5 Currently,
the prospective, multicenter Exercise Therapy for Periph-
eral Arterial Disease (EXITPAD) trial is being performed to
study the effectiveness and cost-effectiveness of SET in a
community-based setting compared with non-SET.
CONCLUSION
Supervised exercise therapy in a community-based set-
ting seems a promising approach to providing conservative
treatment for patients with intermittent claudication. Once
the reproducibility of our results has been established in
other parts of the Netherlands, such as in the ongoing
EXITPAD study or by initiatives elsewhere, the possibilities
for implementing community-based SET must be ex-
plored.
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Table II. Mean percentage increase in walking distances
Initial claudication distance
Follow-up Mean %  SD* Range
1 month 80.9 (402.0) –53.9 to 5
3 months 187.3 (187.1) –25.5 to 7
6 months 240.2 (284.2) –39.8 to 1
SD, Standard deviation.
*P  .0001 for all data.
Table III. Increase in absolute claudication distance or ab
exercise therapy in patients with primary claudication
Trial Patients (n) Durati
Cheetham6 28 
Degischer14 19 
Kakkos7 8 
Savage16 11 
Nielsen8 25 
Patterson4 25 
Regensteiner15 10 
Mean % increase overall
ET, Exercise therapy; ACD, absolute claudication distance; ACT, absoluteOverall responsibility: JTREFERENCES
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